AITrending across 2 sourcesTechCrunch AI1h ago
OpenAI acquires startup Orchestra Bio to beef up its biotech business
TL;DROpenAI bought Orchestra Bio to strengthen its biotech AI research capabilities.
Why it matters: AI models entering drug discovery and life sciences could accelerate research timelines and reshape pharma R&D competition.
OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
Read full articleSource: TechCrunch AI · Opens in new tab